These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 30414866)

  • 1. Structural Characterization and Pharmaceutical Properties of Three Novel Cocrystals of Ethenzamide With Aliphatic Dicarboxylic Acids.
    Kozak A; Marek PH; Pindelska E
    J Pharm Sci; 2019 Apr; 108(4):1476-1485. PubMed ID: 30414866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical properties of two ethenzamide-gentisic acid cocrystal polymorphs: Drug release profiles, spectroscopic studies and theoretical calculations.
    Sokal A; Pindelska E; Szeleszczuk L; Kolodziejski W
    Int J Pharm; 2017 Apr; 522(1-2):80-89. PubMed ID: 28274662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Salt-Cocrystals of Berberine Hydrochloride with Aliphatic Dicarboxylic Acids: Odd-Even Alternation in Physicochemical Properties.
    Wang L; Liu S; Chen JM; Wang YX; Sun CC
    Mol Pharm; 2021 Apr; 18(4):1758-1767. PubMed ID: 33656348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectroscopic analysis of the influence of various external factors on ethenzamide-glutaric acid (1:1) cocrystal formation.
    Kozak A; Pindelska E
    Eur J Pharm Sci; 2019 May; 133():59-68. PubMed ID: 30910648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization.
    Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A
    J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocrystals of acyclovir with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
    Ober CA; Gupta RB
    AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecular Cocrystals of Gliclazide: Synthesis, Characterization and Evaluation.
    Chadha R; Rani D; Goyal P
    Pharm Res; 2017 Mar; 34(3):552-563. PubMed ID: 28035627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method.
    Chaudhari KR; Savjani JK; Savjani KT; Shah H
    Drug Dev Ind Pharm; 2021 Oct; 47(10):1633-1642. PubMed ID: 35156497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Aceclofenac Cocrystals with l-Cystine: Virtual Coformer Screening, Mechanochemical Synthesis, and Physicochemical Investigations.
    Kumar S; Gupta A; Prasad R; Singh S
    Curr Drug Deliv; 2021; 18(1):88-100. PubMed ID: 32807053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
    Boksa K; Otte A; Pinal R
    J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol cocrystals with enhanced solubility and tabletability.
    Zhou Z; Li W; Sun WJ; Lu T; Tong HHY; Sun CC; Zheng Y
    Int J Pharm; 2016 Jul; 509(1-2):391-399. PubMed ID: 27282539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, structural analysis, and properties of tenoxicam cocrystals.
    Patel JR; Carlton RA; Needham TE; Chichester CO; Vogt FG
    Int J Pharm; 2012 Oct; 436(1-2):685-706. PubMed ID: 22841852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
    Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M
    Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and physicochemical characterization of acyclovir cocrystals with improved dissolution properties.
    Bruni G; Maietta M; Maggi L; Mustarelli P; Ferrara C; Berbenni V; Milanese C; Girella A; Marini A
    J Pharm Sci; 2013 Nov; 102(11):4079-86. PubMed ID: 24030886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
    Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
    Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of Carbamazepine Cocrystals: Characterization,
    Wasim M; Mannan A; Asad MHHB; Amirzada MI; Shafique M; Hussain I
    Biomed Res Int; 2021; 2021():6685806. PubMed ID: 33816628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocrystal Construction Between Rosuvastatin Calcium and L-asparagine with Enhanced Solubility and Dissolution Rate.
    Vemuri VD; Lankalapalli S
    Turk J Pharm Sci; 2021 Dec; 18(6):790-798. PubMed ID: 34979738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.